DiaCarta Lands $8,000,000 Series A Financing

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=9d0b0c7b-675b-4181-8de2-27190014e241
Date
1/10/2015
Company Name
DiaCarta
Mailing Address
3535 Breakwater Ave. Hayward, CA 94545 USA
Company Description
DiaCarta provides precise cancer molecular tests including NRAS, EGFR and KRAS mutation test kits, PCR ready lysis kit, HPV E6/E7 mRNA test kits for cervical and head-neck cancer, cancer biomarker gene expression detection kits and superfast master mix.
Website
http://www.diacarta.com
Transaction Type
Venture Equity
Transaction Amount
$8,000,000
Transaction Round
Series A
Proceeds Purposes
Proceeds from Series A financing will be used to expand the product portfolio and support global commercialization.
M&A Terms
Venture Investor